Clinical trial
Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection; Studies From Korea
NCT02401477 is registered in ClinicalTrials.gov with Il-Yang Pharm. Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection; Studies From Korea
- Lead sponsor
- Il-Yang Pharm. Co., Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- June 30, 2015
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.